ATP5C1 Human

ATP Synthase Gamma Chain, Mitochondria Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to ATP5C1 Human

ATP5C1 (ATP synthase subunit gamma, mitochondrial) is a nuclear-encoded gene located on human chromosome 10 (10p15.1) . It encodes the gamma subunit of mitochondrial ATP synthase (Complex V), a critical enzyme for ATP production during oxidative phosphorylation . This enzyme catalyzes ATP synthesis by harnessing the proton gradient across the mitochondrial inner membrane .

Key Features:

  • Gene ID: 509 (NCBI), P36542 (UniProt) .

  • Transcript Variants: Alternative splicing produces tissue-specific isoforms, including liver (L) and heart (H) variants differing by a single amino acid (Asp273) .

  • Pseudogene: Located on chromosome 14 .

Protein Structure and Isoforms

The gamma subunit is part of the F₁ catalytic domain of ATP synthase, which includes α, β, γ, δ, and ε subunits . Its structure includes:

  • Domain: ATPase gamma chain family .

  • Molecular Weight: 32.6–33 kDa (296–298 amino acids) .

  • Isoforms: Liver (L) and heart (H) variants differ in C-terminal residues, influencing enzyme activity .

Table 1: ATP Synthase Subunit Composition

SubunitRoleStoichiometry
α (ATP5A1)Catalytic core3 copies
β (ATP5B)Catalytic core3 copies
γ (ATP5C1)Central stalk1 copy
δ (ATP5D)Peripheral stalk1 copy
ε (ATP5E)Regulatory1 copy

Source:

Tissue-Specific Expression

ATP5C1 is ubiquitously expressed but shows elevated activity in energy-demanding tissues:

  • High Expression: Heart, liver, skeletal muscle, and brain .

  • Low Expression: Adipose tissue and blood cells .

Role in ATP Synthesis and Proton Transport

ATP5C1 facilitates rotary catalysis by coupling proton translocation (via the F₀ subunit) to ATP synthesis . Mutations in ATP synthase subunits (e.g., δ subunit) disrupt assembly, reducing ATP production and mitochondrial cristae density .

Disease Associations and Pathophysiology

While ATP5C1-specific mutations are not yet linked to human diseases, ATP synthase deficiencies are implicated in:

  • Mitochondrial Disorders: Complex V deficiency, Batten disease, and neurodegeneration .

  • Mechanisms: Impaired subunit assembly, altered proton channel activity, or c-ring aggregation .

Table 2: ATP Synthase-Related Diseases

DiseaseSubunit AffectedPathological Features
Complex V Deficiencyδ, a, cReduced ATP synthesis, mitochondrial dysfunction
Batten Diseasec-subunitLysosomal accumulation, neurodegeneration
Hypertrophic CardiomyopathyGTPBP3tRNA metabolism defects, ATP synthase dysfunction

Source:

Emerging Roles in Mitochondrial Permeability Transition (mPT)

The c-subunit of F₀ forms a voltage-gated ion channel (ACLC), which is inhibited by F₁ binding . Dissociation of F₁ from F₀ during stress (e.g., glutamate toxicity) triggers mitochondrial permeability transition .

Recombinant Proteins and Antibodies

  • Recombinant ATP5C1: Expressed in E. coli (His-tagged, 26–298 aa), used in SDS-PAGE and Western blot .

  • Antibodies: Monoclonal (e.g., 60284-1-Ig) validated for WB, IHC, and flow cytometry .

Table 3: Research Tools for ATP5C1

ToolSourceApplicationsValidated Samples
Recombinant ProteinE. coliSDS-PAGE, WBHuman heart, fetal brain
Antibody (60284-1-Ig)ProteintechWB, IHC, IFLiver cancer, HepG2 cells
ELISA KitMyBioSourceQuantitative detectionSerum, plasma, tissue homogenates

Source:

Functional Assays

  • SDS-PAGE: Detection of ATP5C1 at 32.6 kDa .

  • Immunohistochemistry: Localization in liver cancer tissue (TE buffer pH 9.0) .

Diagnostic Challenges

ATP5C1 is classified as Amber in mitochondrial disorder panels due to insufficient evidence linking mutations to disease .

Future Directions

  • Therapeutic Targets: Modulating F₁-F₀ interactions to prevent mPT in neurodegeneration .

  • Biomarkers: ELISA kits for monitoring ATP5C1 levels in metabolic disorders .

Product Specs

Introduction
ATP synthase subunit gamma, mitochondrial isoform L (liver) (ATP5C1), also known as ATP5CL1, is a crucial component of the mitochondrial ATP synthase complex. This enzyme plays a vital role in cellular energy production by catalyzing ATP synthesis using a proton gradient across the inner mitochondrial membrane during oxidative phosphorylation. The catalytic core of ATP synthase consists of five distinct subunits: alpha, beta, gamma, delta, and epsilon. These subunits are assembled in a specific stoichiometry of 3 alpha, 3 beta, and one of each of the remaining subunits. ATP5C1, as a member of the ATPase gamma chain family, is essential for the proper assembly and function of this complex.
Description
This product consists of a recombinant human ATP5C1 protein expressed in E. coli. It is a single, non-glycosylated polypeptide chain comprising 296 amino acids (residues 26-298). The protein has a molecular weight of 32.6 kDa. For purification and detection purposes, it is tagged with a 23 amino acid His-tag at the N-terminus. The purification process involves proprietary chromatographic techniques to ensure high purity.
Physical Appearance
The product appears as a clear, sterile-filtered solution.
Formulation
The ATP5C1 protein is provided in a solution containing 0.5 mg/ml of the protein, 20mM Tris-HCl buffer (pH 8.0), 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the product should be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To further enhance stability during long-term storage, adding a carrier protein such as HSA or BSA (0.1%) is advisable. It's important to avoid repeated freeze-thaw cycles to maintain product integrity.
Purity
The purity of the ATP5C1 protein is greater than 90%, confirmed through SDS-PAGE analysis.
Synonyms
ESE3, ESE3B, ESEJ, F-ATPase gamma subunit, ATP5C1, ATP5CL1, ATP5C, ATP synthase subunit gamma, mitochondrial.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSATLKDIT RRLKSIKNIQ KITKSMKMVA AAKYARAERE LKPARIYGLG SLALYEKADI KGPEDKKKHL LIGVSSDRGL CGAIHSSIAK QMKSEVATLT AAGKEVMLVG IGDKIRGILY RTHSDQFLVA FKEVGRKPPT FGDASVIALE LLNSGYEFDE GSIIFNKFRS VISYKTEEKP IFSLNTVASA DSMSIYDDID ADVLQNYQEY NLANIIYYSL KESTTSEQSA RMTAMDNASK NASEMIDKLT LTFNRTRQAV ITKELIEIIS GAAALD.

Q&A

What is ATP5C1 and what is its functional role in human cells?

ATP5C1 (ATP synthase F1 subunit gamma) is an essential component of the mitochondrial ATP synthase complex that plays a critical role in oxidative phosphorylation. It functions as part of the central rotor shaft within the F1 catalytic domain, facilitating the conversion of ADP to ATP using the proton gradient established across the inner mitochondrial membrane. Recent genome-wide RNA-interactome studies have identified ATP5C1 as a RNA-binding protein (RBP) across various eukaryotes, including humans .

ATP5C1 is encoded by the nuclear genome, synthesized as a precursor protein in the cytosol, and subsequently imported into mitochondria where it assembles into the functional ATP synthase complex. Similar to other F1-ATP synthase subunits like ATP5A1 and ATP5B, ATP5C1 has been found to interact with cellular RNAs, which may play regulatory roles in its mitochondrial import process.

How should researchers approach studying ATP5C1's RNA-binding properties?

When investigating ATP5C1's RNA-binding capabilities, researchers should implement a comprehensive approach:

  • Target Identification:

    • Apply enhanced Crosslinking and Immunoprecipitation (eCLIP-Seq) to identify transcriptome-wide RNA interactions

    • Include appropriate controls (IgG pulldown, size-matched inputs)

    • Use robust computational analysis pipelines like DEW-Seq

  • Binding Characterization:

    • Analyze binding patterns using metagene plots to visualize distribution across transcripts

    • Perform motif discovery to identify potential sequence preferences

    • Compare binding patterns with other ATP synthase subunits like ATP5A1

  • Functional Validation:

    • Develop RNA-binding deficient mutants by mutating positively charged residues

    • Confirm reduced binding using RNA immunoprecipitation followed by qPCR (RIP-qPCR)

    • Validate protein folding and complex assembly through co-immunoprecipitation with partner proteins (ATP5A1, ATP5B)

  • Subcellular Localization:

    • Use RNA-protein proximity ligation assays (RNA-PLA) to visualize interactions in situ

    • Co-stain with mitochondrial markers (e.g., TOM70) to determine where interactions occur

This methodical approach ensures comprehensive characterization of ATP5C1's RNA-binding capabilities while maintaining experimental rigor.

What experimental models are most appropriate for studying ATP5C1?

Based on current research approaches, several experimental models have proven effective for studying different aspects of ATP5C1 biology:

Model SystemApplicationsAdvantagesLimitations
Human hepatoma cell lines (e.g., Huh7)RNA binding studies, protein localizationWell-characterized, amenable to genetic manipulationMay not represent tissue-specific functions
Inducible expression systemsStructure-function analysisControlled expression of wild-type and mutant proteinsPotential artifacts from overexpression
Isolated mitochondriaImport assaysDirect assessment of ATP5C1 import kineticsLimited timeframe for experiments
Recombinant protein systemsBiochemical assays, structural studiesAllows precise manipulation of protein sequenceLacks cellular context
Patient-derived cellsDisease-relevant studiesCaptures pathological contextGenetic variability between samples

When selecting an experimental model, researchers should consider the specific aspect of ATP5C1 biology under investigation. For example, studies of RNA-binding properties and mitochondrial import may benefit from cellular systems that maintain the native cytosolic-mitochondrial interface, while structural studies might require purified recombinant proteins .

How does ATP5C1's RNA-binding profile compare to other ATP synthase subunits?

While comprehensive characterization of ATP5C1's RNA interactome is still emerging, comparative analyses with other ATP synthase subunits reveal distinct binding profiles:

ATP5C1 exhibits RNA-binding properties that appear distinct from ATP5A1, another subunit of the F1-ATP synthase complex. eCLIP-Seq analysis has demonstrated that ATP5C1 binds to RNA regions that differ from those bound by ATP5A1 . This suggests specialized functions in RNA metabolism despite belonging to the same protein complex.

ATP5A1, by comparison, has been extensively characterized:

  • Binds predominantly to cytosolic mRNAs (~86% of targets)

  • Recognizes distinct sequence motifs: a ~10-nucleotide polypyrimidine (CU) motif in 5'UTRs and a ~20-nucleotide G-rich motif in 3'UTRs/CDS regions

  • Shows enrichment for mRNAs involved in translation, particularly those containing TOP motifs

More detailed comparative studies are needed to fully elucidate ATP5C1's binding preferences and target specificity, which could reveal functional specialization among ATP synthase subunits in RNA metabolism.

What experimental design strategies are optimal for investigating ATP5C1's role in mitochondrial import?

When studying ATP5C1's potential role in mitochondrial import, researchers should implement a multi-faceted experimental approach incorporating principles of true experimental design:

In vitro Import Assays:

  • Generate labeled ATP5C1 precursor using in vitro translation with 35S-methionine

  • Isolate human mitochondria and divide into treatment groups:

    • RNase-treated vs. mock-treated controls

    • Membrane potential-dissipated vs. intact controls

  • Monitor import and processing by gel electrophoresis over a time course (typically 10 minutes)

  • Include control proteins (e.g., ornithine transcarbamylase) to demonstrate specificity

Cellular Import Studies:

  • Create constructs with varied mitochondrial targeting signals (MTS):

    • Wild-type MTS (wtMTS)

    • Engineered MTS (eMTS) with integrated tags

    • MTS-deleted controls (noMTS)

  • Develop RNA-binding deficient mutants in these backgrounds

  • Monitor localization using confocal microscopy

  • Quantify mature vs. precursor forms by immunoblotting

This comprehensive approach follows true experimental design principles by incorporating:

  • Randomization of samples

  • Multiple control conditions

  • Measurement of both before and after treatment states

  • Statistical analysis of results using repeated measures ANOVA with appropriate post-hoc tests

How can researchers effectively create and validate RNA-binding deficient mutants of ATP5C1?

Based on successful approaches with similar proteins such as ATP5A1, researchers can employ the following strategy to create and validate RNA-binding deficient mutants of ATP5C1:

Mutation Design Strategy:

  • Analyze protein structure using tools like AlphaFold2

  • Identify surface-exposed, positively charged residues (Arg, Lys) likely to interact with RNA

  • Create multiple mutants targeting different regions:

    • Single mutations for targeted analysis

    • Combined mutations for stronger effect

    • Focus on residues outside known functional domains

Validation Protocol:

Validation ParameterMethodologyExpected Outcome
RNA bindingRIP-qPCR with specific target RNAsSignificant reduction in RNA enrichment compared to wild-type
Protein foldingCircular dichroism spectroscopySimilar secondary structure profile to wild-type
Complex assemblyCo-immunoprecipitation with partner proteinsMaintained interaction with ATP5A1, ATP5B, and ATP5F1
Subcellular localizationConfocal microscopy with mitochondrial co-stainProper mitochondrial localization
Functional integritySeahorse respirometryComparable oxygen consumption rate when replacing endogenous protein

Functional Assessment:

  • Compare import kinetics between wild-type and mutant proteins

  • Monitor ATP production capacity

  • Assess impact on cellular respiration and mitochondrial membrane potential

This systematic approach ensures that any phenotypes observed can be specifically attributed to disrupted RNA binding rather than to general protein dysfunction or misfolding .

What statistical approaches are recommended for analyzing ATP5C1 eCLIP-Seq data?

For robust analysis of ATP5C1 eCLIP-Seq data, researchers should implement a comprehensive statistical framework:

Data Processing Pipeline:

  • Quality Control:

    • Filter low-quality reads (PHRED score < 20)

    • Remove PCR duplicates using unique molecular identifiers

    • Trim adapters and barcode sequences

  • Alignment:

    • Map to reference genome using splice-aware aligners (STAR, HISAT2)

    • Filter multi-mapping reads

  • Peak Calling:

    • Apply DEW-Seq analysis pipeline designed for eCLIP data

    • Identify enriched regions using stringent criteria:

      • Mean adjusted p-value < 0.05

      • Mean IP crosslinking counts > 25

      • Mean Log2 fold change ≥ 1 compared to size-matched input

Statistical Analysis Framework:

Analysis TypeStatistical MethodPurpose
Differential bindingDESeq2 or edgeRIdentify significantly enriched regions
Multiple testing correctionBenjamini-Hochberg procedureControl false discovery rate
Motif enrichmentMEME suite, HOMERIdentify sequence preferences
Gene ontologyHypergeometric testFunctional enrichment of target RNAs
Metagene analysisNormalized coverage plotsVisualize binding distribution
Validation comparisonANOVA with Holm-Šidák post-hoc testCompare RNA-PLA counts between targets

This comprehensive analytical approach ensures reliable identification of ATP5C1's RNA interactome while minimizing false positives and enabling biological interpretation of binding patterns.

What controls should be included when studying ATP5C1-RNA interactions?

When investigating ATP5C1-RNA interactions, comprehensive controls are essential to ensure specificity and reliability of findings:

Essential Controls for RNA-Binding Studies:

Control TypePurposeImplementation
Input ControlsNormalize for RNA abundanceInclude total RNA/lysate before immunoprecipitation (5-10%)
Use size-matched input for eCLIP-seq
Negative ControlsAccount for non-specific bindingIgG immunoprecipitation (matching isotype)
ATP5C1 knockdown/knockout cells
Non-target RNAs (e.g., FTH1)
"No probe" controls in RNA-PLA experiments
Positive ControlsVerify assay functionalityKnown RNA-binding proteins (e.g., PTBP1)
Well-characterized RBP-RNA interactions
Specificity ControlsValidate binding specificityRNA-binding deficient mutants
Competition with excess unlabeled RNA
RNase A treatment
Technical ControlsMonitor technical variabilityTechnical replicates
Spike-in controls for sequencing

Experimental Design Considerations:

  • Implement true experimental designs with randomization when possible

  • Consider Solomon four-group design to control for testing effects in cellular studies

  • Include at least three biological replicates for statistical power

  • Perform blinded analysis of imaging data to prevent bias

These comprehensive controls are critical for distinguishing genuine ATP5C1-RNA interactions from experimental artifacts and for ensuring reproducibility across different experimental conditions.

How can researchers measure the functional consequences of ATP5C1's RNA interactions?

To assess the functional impact of ATP5C1's RNA interactions, researchers should employ a multi-parameter approach that examines several aspects of ATP5C1 and mitochondrial biology:

Mitochondrial Import Assessment:

  • Compare import kinetics between wild-type and RNA-binding deficient mutants

  • Conduct in vitro import assays with and without RNase treatment

  • Measure the ratio of processed (mature) to unprocessed (precursor) protein over time

  • Quantify import efficiency under various cellular stress conditions

ATP Synthase Assembly and Function:

ParameterMethodologyExpected Outcome if RNA Binding is Functional
Complex assemblyBlue native PAGEReduced assembly in RNA-binding mutants
ATP productionLuminescence-based ATP assaysDecreased ATP synthesis capacity
Proton pumpingACMA fluorescence quenchingAltered proton translocation efficiency
Enzyme activityATPase activity assaysReduced enzymatic function

Cellular Energetics Analysis:

  • Measure oxygen consumption rate (OCR) using Seahorse respirometry

  • Compare baseline, ATP-linked, and maximal respiration

  • Assess mitochondrial membrane potential using fluorescent probes

  • Evaluate metabolic flexibility through substrate utilization studies

Physiological Response Assessment:

  • Monitor cell growth and proliferation

  • Assess resistance to metabolic stress

  • Measure reactive oxygen species production

  • Evaluate mitochondrial dynamics (fusion/fission)

What are the optimal protocols for ATP5C1 antibody validation?

Rigorous antibody validation is crucial for reliable ATP5C1 research, particularly for techniques like immunoprecipitation and eCLIP-seq. Researchers should implement the following comprehensive validation protocol:

Antibody Validation Protocol:

  • Specificity Testing:

    • Western blot analysis comparing wild-type and ATP5C1 knockdown samples

    • Probing multiple cell lines to confirm consistent detection

    • Testing with recombinant ATP5C1 as positive control

    • Evaluating cross-reactivity with other ATP synthase subunits

  • Application-Specific Validation:

ApplicationValidation MethodAcceptance Criteria
ImmunoblottingSerial dilution analysisSingle band at expected MW, linear signal response
ImmunoprecipitationMass spectrometry of pulldownATP5C1 as top hit, enrichment of known interactors
ImmunofluorescenceColocalization with mitochondrial markers>90% overlap with mitochondrial staining
Comparison with second ATP5C1 antibodyConcordant staining pattern
eCLIP-seqMock IP control comparison>10-fold enrichment over mock IP
Testing with RNA-binding deficient mutantsReduced signal with mutants
  • Reporting Standards:

    • Document antibody source, catalog number, lot number, and dilution

    • Report validation results including positive and negative controls

    • Archive validation data for reference

Thorough antibody validation is essential as it directly impacts the reliability of downstream analyses. For eCLIP-seq experiments, antibody specificity is particularly critical as non-specific binding can lead to false identification of RNA targets .

How might ATP5C1's RNA-binding properties contribute to mitochondrial function?

The RNA-binding capacity of ATP5C1 may represent a previously unrecognized regulatory mechanism affecting mitochondrial function through several potential pathways:

Potential Functional Roles:

  • Regulated Mitochondrial Import:
    Similar to ATP5A1, ATP5C1's RNA interactions may facilitate its import into mitochondria. Studies with ATP5A1 have demonstrated that RNA promotes mitochondrial import both in vitro and in cellulo . Given that ATP5C1 belongs to the same complex, it may share this regulatory mechanism.

  • Coordinated Complex Assembly:
    RNA binding might synchronize the import and assembly of different ATP synthase subunits, ensuring stoichiometric assembly of the complex. This would be particularly important during increased energy demands when coordinated upregulation of all subunits is necessary.

  • Response to Cellular Stress:
    RNA interactions could modulate ATP5C1 import in response to various cellular stresses, providing a rapid mechanism to adjust mitochondrial ATP production capacity without requiring transcriptional changes.

  • Cross-talk with Cytosolic Translation:
    The observation that ATP5A1 binds mRNAs involved in translation, particularly those with TOP motifs , suggests these interactions might coordinate energy production with translational activity—a major consumer of cellular ATP.

Experimental Evidence from Related Proteins:

  • RNase treatment significantly reduces ATP5A1 import rate in isolated mitochondria

  • ATP5A1 interacts with RNAs at the outer mitochondrial membrane

  • RNA-binding deficient mutants of ATP5A1 show altered import dynamics

Understanding ATP5C1's RNA-binding function could reveal new regulatory mechanisms governing mitochondrial bioenergetics and provide insights into diseases characterized by mitochondrial dysfunction.

What is the significance of ATP5C1 research for understanding human diseases?

ATP5C1 research has significant implications for understanding various human diseases, particularly those involving mitochondrial dysfunction:

Disease Relevance of ATP5C1:

Disease CategoryPotential ATP5C1 ConnectionResearch Implications
Neurodegenerative Disorders- Progressive deregulation of ATP synthase in pathogenesis
- Energy deficits in neuronal cells
- Disrupted protein import
Research could reveal how altered ATP5C1 function contributes to energy deficits in Alzheimer's, Parkinson's, and ALS
Metabolic Diseases- Altered ATP production capacity
- Disrupted energy homeostasis
- Compromised response to metabolic demands
Studies may uncover ATP5C1's role in insulin resistance, obesity, and metabolic syndrome
Cardiovascular Disorders- Energy supply-demand mismatch in cardiac tissue
- ATP synthase dysfunction in heart failure
Findings could explain energy deficits in failing myocardium and identify new therapeutic targets
Cancer- Metabolic reprogramming in tumor cells
- Altered mitochondrial function
Research might reveal how cancer cells modulate ATP5C1 to support their bioenergetic requirements

Clinical Research Directions:

  • Analyze ATP5C1 expression, localization, and RNA-binding in patient-derived samples

  • Examine genetic variants affecting ATP5C1's RNA-binding capacity

  • Develop therapeutic approaches targeting ATP5C1-RNA interactions

  • Explore ATP5C1 as a biomarker for mitochondrial dysfunction

Understanding the relationship between ATP5C1's RNA-binding properties and disease pathogenesis could open new avenues for diagnostic and therapeutic interventions targeting mitochondrial function in various pathological conditions .

What emerging technologies might enhance our understanding of ATP5C1 biology?

Several cutting-edge technologies hold promise for advancing ATP5C1 research:

Emerging Technologies for ATP5C1 Research:

TechnologyApplication to ATP5C1 ResearchPotential Insights
Cryo-Electron Microscopy- Visualize ATP5C1-RNA complexes
- Determine binding interfaces
- Study conformational changes
Structural basis of RNA recognition and its impact on protein conformation
Single-Molecule Techniques- FRET analysis of ATP5C1-RNA interactions
- Optical tweezers to measure binding kinetics
- Super-resolution imaging of import process
Real-time dynamics of RNA binding and its effect on mitochondrial import
CRISPR-Based Technologies- Base editing for precise mutagenesis
- CRISPRi/CRISPRa for expression modulation
- Prime editing for specific mutations
Functional consequences of specific RNA-binding domains or motifs
Spatial Transcriptomics- Map ATP5C1-RNA interactions in situ
- Correlate with mitochondrial distribution
- Analyze cell type-specific patterns
Spatial organization of interactions and their relationship to mitochondrial networks
Microfluidics and Organ-on-Chip- High-throughput screening of RNA ligands
- Real-time monitoring of import kinetics
- Analysis in physiologically relevant systems
Identification of optimal RNA partners and physiological relevance

Integration with Experimental Design:

These technologies should be implemented within rigorous experimental frameworks, including:

  • Randomized controlled designs when possible

  • Appropriate control conditions

  • Multiple biological replicates

  • Blinded analysis of results

By combining these advanced technologies with sound experimental design principles, researchers can gain unprecedented insights into ATP5C1's biology and its roles in cellular homeostasis and disease .

How can researchers design experiments to study ATP5C1's role in disease models?

When investigating ATP5C1's role in disease models, researchers should implement a systematic experimental approach:

Experimental Design Framework:

  • Model Selection:

    • Choose disease-relevant cell types (e.g., neurons for neurodegenerative disorders)

    • Consider patient-derived samples when available

    • Develop appropriate in vivo models

  • Experimental Design Structure:

    • Implement true experimental designs with randomization

    • Include appropriate control groups

    • Consider Solomon four-group design to control for testing effects

    • Use stratified randomization for heterogeneous samples

  • ATP5C1 Manipulation Strategies:

ApproachMethodologyApplication
Genetic ModulationCRISPR/Cas9 knockout or knockinCreate complete loss-of-function or point mutations
siRNA/shRNA knockdownAchieve temporary reduction in expression
Inducible expression systemsControl timing and level of expression
Functional ModulationRNA-binding deficient mutantsSpecifically target RNA-binding function
MTS modificationsAlter mitochondrial import efficiency
Small molecule modulatorsTarget ATP5C1 or its RNA interactions
  • Comprehensive Assessment:

    • Measure mitochondrial function (respirometry, membrane potential)

    • Assess ATP production capacity

    • Evaluate cellular stress responses

    • Monitor disease-relevant phenotypes

    • Compare RNA-binding patterns between disease and control samples

  • Data Analysis:

    • Apply appropriate statistical tests based on experimental design

    • Control for multiple comparisons

    • Consider repeated measures designs for time-course experiments

    • Use multivariate analysis to integrate multiple parameters

By following rigorous experimental design principles and incorporating appropriate controls , researchers can generate reliable insights into ATP5C1's role in disease pathogenesis, potentially identifying new therapeutic targets.

Product Science Overview

Introduction

ATP synthase is a crucial enzyme found in the mitochondria, responsible for the synthesis of adenosine triphosphate (ATP), the primary energy carrier in cells. The enzyme operates by utilizing an electrochemical gradient of protons across the inner mitochondrial membrane during oxidative phosphorylation .

Structure and Function

ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, which comprises the proton channel . The catalytic portion of mitochondrial ATP synthase consists of five different subunits: alpha, beta, gamma, delta, and epsilon. These subunits are assembled with a stoichiometry of three alpha, three beta, and a single representative of the other three .

The gamma subunit, encoded by the ATP5C1 gene, plays a pivotal role in the catalytic core of ATP synthase. It is involved in the rotational mechanism that drives ATP synthesis . The gamma subunit interacts with the alpha and beta subunits, facilitating the conformational changes necessary for ATP production .

Recombinant Production

The human recombinant ATP synthase gamma chain is typically produced in Escherichia coli (E. coli) expression systems. The recombinant protein is often fused to a His-tag at the N-terminus to facilitate purification through affinity chromatography . The purified protein is used in various research applications, including structural and functional studies of ATP synthase .

Applications

Recombinant ATP synthase gamma chain is used in research to understand the enzyme’s mechanism and its role in cellular energy metabolism. It is also employed in studies investigating mitochondrial diseases and potential therapeutic interventions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.